Testing a Glowing Dye to Improve Brain Tumor Removal
Part of Brain & nervous system, Cancer clinical trials.
This trial compares two surgical techniques for removing malignant brain tumors: one using a special dye (5-ALA) that makes tumor cells glow under a blue light, versus the standard white light surgery. The goal is to see if the dye-guided approach helps surgeons remove more of the tumor safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have a newly diagnosed malignant glioma (a type of aggressive brain tumor) that is grade 3 or 4.
- Your overall health status allows you to perform daily activities without needing bed rest more than half the day (KPS score of 60 or higher).
- You are able to swallow pills.
- You do not have porphyria or a history of severe skin reactions to light.
- Your tumor is not located in the brainstem, deep brain areas, or cerebellum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special dye called 5-ALA can help doctors see brain tumors more clearly during surgery. You may be able to join if you are scheduled for surgery to remove a suspected high-grade glioma.
This trial tests a drug called 5-ALA that helps surgeons see tumor cells more clearly during surgery. It is for children and teens with high-grade brain tumors who are having surgery to remove the tumor.
This study tests whether a special dye called 5-ALA can help surgeons see tumor tissue more clearly during brain tumor surgery. If you are having surgery for a high-grade glioma or another brain tumor, you may be able to join and help improve surgical precision.
This trial tests whether a drug called 5-ALA, given before surgery, can help surgeons see and remove pediatric brain tumors more completely. It may be an option for children with specific types of brain tumors that are planned for removal.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
Hear when a new 5-aminolevulinic Acid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.